News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Opinion: Should Scientists Engage in Activism?
Adam Marcus and Ivan Oransky | Feb 7, 2017
Scientists who accept funding with the tacit agreement that they keep their mouths shut about the government are far more threatening to an independent academy than those who speak their minds.
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
John D. Loike and Jennifer Miller | Feb 1, 2017
What can be done to lower development costs and drug prices?
Opinion: Preparing for Potential Disasters
Larissa Paschyn | Jan 25, 2017
How to increase the resiliency of biotechnology organizations in the face of emergency risks
Opinion: Reuse and Reduce
Valerie Speirs | Jan 16, 2017
Sharing leftover samples from preclinical experiments is one way biomedical researchers can make the most of animal models.
Opinion: A Tale of Two Hemispheres
Laurence O’Dwyer | Dec 20, 2016
Studying savant-like behaviors in birds could help researchers better understand autism spectrum disorders.
Opinion: The Scientist’s Scarlet Letter
Paul S. Thaler | Dec 16, 2016
Managing privacy protections and expectations in a misconduct proceeding
Opinion: Balancing Risks and Rewards of CAR T-Cell Therapy
David Harris | Dec 15, 2016
New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.
Opinion: WHO’s Silence on Cannabis
Ian Hamilton, Steve Rolles, Mark Monaghan | Nov 29, 2016
Why the World Health Organization needs a radical rethink of its draconian approach to cannabis
Opinion: The Impact Factor, Re-envisioned
Shibo Jiang, Haoyang Li, Yan Wang | Nov 18, 2016
A combination of the traditional metric and the newer h5 index potentiates the scientific community toward more-balanced evaluation.
Opinion: Repairing Peer Review
Tricia Serio | Nov 18, 2016
Peer review is in crisis, but should be fixed, not abolished.